Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

The frequency of adverse events in non-infectious uveitis patients treated with TNF inhibitors

Chisato Agata; Toshikatsu Kaburaki; Rie Tanaka; Keiko Komae; Hidetomo Izawa; Hisae Nakahara; Hidetoshi Kawashima; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3523. doi:

ARVO Annual Meeting Abstract July 2019

Frequency of uveitis in Central Tokyo area (2016-2018)

Takafumi Suzuki; Toshikatsu Kaburaki; Rie Tanaka; Hisae Nakahara; Shintaro Shirahama; Keiko Komae; Jummi Tanaka; Hidetomo Izawa; Mitsuko Takamoto; Ayako Karakawa; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6659. doi:

ARVO Annual Meeting Abstract July 2018

Clinical features and visual outcome of uveitis in children and adolecents

Marie Kitano; Rie Tanaka; Toshikatsu Kaburaki; Hisae Nakahara; Hidetomo Izawa; Mitsuko Takamoto; Yujiro Fujino

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4163. doi:

ARVO Annual Meeting Abstract July 2018

Validation of Revised International Criteria for the Diagnosis of Ocular Sarcoidosis Proposed by International Workshop on Ocular Sarcoidosis

Toshikatsu Kaburaki; Rie Tanaka; Hisae Nakahara; Jummi Tanaka; Mitsuko Takamoto; Hidetomo Izawa; Hisako Ono; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4192. doi:

ARVO Annual Meeting Abstract June 2017

Two-year outcomes of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab

Hidetomo Izawa; Keiko Azuma; Aya Matsuda; Kimiko Shimizu; xue tan; Tatsuya Inoue; Ryo Obata

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):879. doi:

Advertisement